Table 1 General characteristics of the study population
Variable | BPO without OAB (n = 892) | BPO with coexisting OAB (n = 584) | P value |
|---|---|---|---|
Prostate volume (mL) | 55.6 ± 20.7 | 62.7 ± 26.5 | 0.005 |
Serum PSA (ng/mL) | 3.6 ± 0.8 | 3.7 ± 0.7 | 0.624 |
Testosterone (nmol/L) | 14.2 ± 4.6 | 13.9 ± 4.3 | 0.196 |
Qmax (mL/s) | 10.2 ± 3.9 | 10.1 ± 3.8 | 0.162 |
PVR (mL) | 19.8 ± 17.3 | 20.5 ± 18.7 | 0.820 |
BMI (kg/m2) | 24.3 ± 3.7 | 24.6 ± 4.1 | 0.461 |
IPSS (score) | 19.2 ± 6.8 | 23.5 ± 7.3 | 0.000 |
QoL (score) | 3.9 ± 0.9 | 4.6 ± 1.2 | 0.000 |
IIEF-5 (score) | 9.9 ± 2.3 | 9.0 ± 1.7 | 0.036 |